JANX008 / Janux Therapeutics  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
JANX008 / Janux Therapeutics
NCT05783622: Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Recruiting
1
130
US
JANX008
Janux Therapeutics
Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck, Colorectal Carcinoma
01/26
10/27

Download Options